ATE313631T1 - Dna polymerase lambda und ihre verwendungen - Google Patents

Dna polymerase lambda und ihre verwendungen

Info

Publication number
ATE313631T1
ATE313631T1 AT00964482T AT00964482T ATE313631T1 AT E313631 T1 ATE313631 T1 AT E313631T1 AT 00964482 T AT00964482 T AT 00964482T AT 00964482 T AT00964482 T AT 00964482T AT E313631 T1 ATE313631 T1 AT E313631T1
Authority
AT
Austria
Prior art keywords
dna polymerase
pol
amino acid
acid sequence
present
Prior art date
Application number
AT00964482T
Other languages
English (en)
Inventor
Davila Luis Blanco
Miana Antonio Bernad
Lopez Orlando Dominguez
Diaz Miguel Garcia
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Application granted granted Critical
Publication of ATE313631T1 publication Critical patent/ATE313631T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
AT00964482T 1999-10-01 2000-10-02 Dna polymerase lambda und ihre verwendungen ATE313631T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902169A ES2189560B1 (es) 1999-10-01 1999-10-01 Dna polimerasa k, nuevo marcador tumoral.
PCT/GB2000/003784 WO2001025442A1 (en) 1999-10-01 2000-10-02 Dna polymerase lambda and uses thereof

Publications (1)

Publication Number Publication Date
ATE313631T1 true ATE313631T1 (de) 2006-01-15

Family

ID=8310115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964482T ATE313631T1 (de) 1999-10-01 2000-10-02 Dna polymerase lambda und ihre verwendungen

Country Status (10)

Country Link
US (2) US7883880B1 (de)
EP (1) EP1218518B1 (de)
JP (1) JP3801917B2 (de)
AT (1) ATE313631T1 (de)
AU (1) AU770704C (de)
CA (1) CA2388363C (de)
DE (1) DE60025011T2 (de)
ES (2) ES2189560B1 (de)
NZ (1) NZ518458A (de)
WO (1) WO2001025442A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002033054A1 (en) * 2000-10-20 2002-04-25 Chugai Seiyaku Kabushiki Kaisha POLYβ2 KNOCKOUT ANIMALS
US10128161B2 (en) 2011-10-27 2018-11-13 Global Circuit Innovations, Inc. 3D printed hermetic package assembly and method
US10002846B2 (en) 2011-10-27 2018-06-19 Global Circuit Innovations Incorporated Method for remapping a packaged extracted die with 3D printed bond connections
US10109606B2 (en) 2011-10-27 2018-10-23 Global Circuit Innovations, Inc. Remapped packaged extracted die
US10177054B2 (en) 2011-10-27 2019-01-08 Global Circuit Innovations, Inc. Method for remapping a packaged extracted die
US10147660B2 (en) 2011-10-27 2018-12-04 Global Circuits Innovations, Inc. Remapped packaged extracted die with 3D printed bond connections
US11993800B2 (en) * 2017-05-26 2024-05-28 Nuclera Ltd. Use of terminal transferase enzyme in nucleic acid synthesis
US10115645B1 (en) 2018-01-09 2018-10-30 Global Circuit Innovations, Inc. Repackaged reconditioned die method and assembly
CN116731184B (zh) * 2022-11-25 2024-06-14 厦门康基生物科技有限公司 一种特异性结合Taq酶的单克隆抗体F6H12及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5085983A (en) * 1988-08-19 1992-02-04 City Of Hope Detection of human tumor progression and drug resistance
AU3989589A (en) * 1988-06-27 1990-01-23 Boehringer Mannheim Corporation Improved biosensor and the method of its use
US5449605A (en) * 1988-10-14 1995-09-12 Georgetown University Method of detecting a predisposition to cancer by detecting a deletion polymorphism in the gene for human poly (ADP-ribose) polymerase
US6222029B1 (en) * 1997-08-01 2001-04-24 Genset 5′ ESTs for secreted proteins expressed in brain
EP1053319A2 (de) 1998-01-28 2000-11-22 Chiron Corporation Menschliche gene und expressionsprodukte ii

Also Published As

Publication number Publication date
EP1218518B1 (de) 2005-12-21
AU770704C (en) 2004-10-14
EP1218518A1 (de) 2002-07-03
ES2258474T3 (es) 2006-09-01
CA2388363A1 (en) 2001-04-12
ES2189560A1 (es) 2003-07-01
CA2388363C (en) 2011-04-12
US7883880B1 (en) 2011-02-08
AU770704B2 (en) 2004-02-26
WO2001025442A1 (en) 2001-04-12
DE60025011D1 (de) 2006-01-26
US20120009648A1 (en) 2012-01-12
AU7541500A (en) 2001-05-10
JP3801917B2 (ja) 2006-07-26
JP2003511033A (ja) 2003-03-25
NZ518458A (en) 2003-08-29
ES2189560B1 (es) 2005-01-01
DE60025011T2 (de) 2006-08-31

Similar Documents

Publication Publication Date Title
PT979308E (pt) Metodo de preparacao de um padrao tipo de um transcrito genetico para diagnostico
WO2003012046A3 (en) Stk15 (stk6) gene polymorphism and methods of determining cancer risk
AU3064200A (en) A method of dna sequencing
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
EP1229134A3 (de) Verwendung von post-transkriptioneller Genabschaltung zur Identifizierung von Nukleinsäuresequenzen die die Funktion einer Zelle beeinflussen
WO2005044990A3 (en) Use of differentially expressed nucleic acid sequences as biomarkers for cancer
WO2007074193A2 (es) Método de análisis de expresión diferencial en cáncer colorectal
DE60039772D1 (de) Verfahren zur amplifikation von signal-flankierend
DE60143314D1 (de) Estimmung der präsenz von cryptosporidium organismen in einer testprobe
ATE313631T1 (de) Dna polymerase lambda und ihre verwendungen
GB2401433A (en) Methods of parallel gene cloning and analysis
DE69808743D1 (en) Netrinrezeptoren
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
Kim et al. ZNF555 protein binds to transcriptional activator site of 4qA allele and ANT1: potential implication in Facioscapulohumeral dystrophy
JP2010502192A5 (de)
Delestré et al. ANKS3 co-localises with ANKS6 in mouse renal cilia and is associated with vasopressin signaling and apoptosis in vivo in mice
ATE255595T1 (de) Nephrin gen und protein
WO2004033485A3 (en) Nucleic acid supported protein complementation
DE69942226D1 (de) Unterschiedlich exprimierte gene in bauchspeicheldrüsen-krebs und -dysplasie
DK0877758T3 (da) Oprenset SR-p70-protein
DE60136746D1 (de) Oligonucleotide zur markierung von oligonukleotidsonden und proteine
ATE315107T1 (de) Verfahren und kit zur früherkennung von krebs
WO2002083081A3 (en) Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms
EP1507787A4 (de) Mit prostatakrebs in zusammenhang stehende zusammensetzungen, verfahren und kits auf grundlage von dna-makroarray-proteom plattformen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties